BioSpace News Archive

Drug Development

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471.

November 15, 2017
·
11 min read
Bedfont Scientific Release: Local, Second-Generation, Family Business Named as a Finalist In 3 Categories for its First Ever Regional Awards

Bedfont Scientific is up for 3 different awards categories in the MISE Awards.

November 15, 2017
·
1 min read
Capital Increase in Genmab as a Result of Employee Warrant Exercise

The company will increase its share capital by 22,532 shares as a consequence of the exercise of employee warrants.

November 15, 2017
·
4 min read
Business

MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board as an Independent Director

Mr. Kanter has more than 30 years of experience in the financial services industry.

November 15, 2017
·
4 min read
Business

BioSyent Releases Results for Third Quarter and First Nine Months of 2017

Third quarter (Q3) 2017 Net Revenues of $5,403,600 increased by 13% versus Q3 2016.

November 15, 2017
·
5 min read
Business

Matinas BioPharma Reports 2017 Third Quarter Financial Results and Provides Corporate Update

For the nine months ended September 30, 2017, the Company reported a net loss of approximately $11.9 million.

November 15, 2017
·
12 min read
Biotech Bay

Guardant Health Release: New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer

The study suggests that patients with these cancers could benefit from targeted therapy based on the detection of biomarkers found with a comprehensive liquid biopsy, but that were absent from their primary tumor.

November 15, 2017
·
3 min read
Business

Genmab Achieves $25M Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance

First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen.

November 15, 2017
·
8 min read
Business

Tempus Announces Latest Immunotherapy Project

The company announced a new research collaboration aimed at identifying which patients will respond positively to immunotherapy treatment, the next generation of cancer care.

November 15, 2017
·
4 min read
Business

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017

The net loss was $1.3 million for the three months ended September 2017 compared to $2.9 million in this period one year ago.

November 15, 2017
·
2 min read